Frazier Life Sciences Management, L.P. - Stock Holdings in 13F Filings (SEC)
Updated on March 15, 2026.
Based on 13F Filings filed with the SEC on February 13, 2026, for the 2025 Q4 period, Frazier Life Sciences Management, L.P. held in its portfolio 40 assets valued at $3,723,154,080 (i.e. $3.72B).
The most valuable assets in the portfolio included: NEWAMSTERDAM PHARMA COMPANY ($594.39M), MIRUM PHARMACEUTICALS INC ($536.75M), and ARCUTIS BIOTHERAPEUTICS INC ($286.76M).
The chart below shows the top 10 valuable assets, and the table below shows the top 40 valuable assets.
You can see similar for other investment managers.
Related Topics: SEC Topic List.
Data Source: SEC.
Frazier Life Sciences Management, L.P. - Stock Holdings in 13F Filings (SEC)
Items per page:
25
0 of 0
| Name of Issuer | No. of Shares | Value ($) | Class |
|---|---|---|---|
| NEWAMSTERDAM PHARMA COMPANY | 16943774 | 594387592 | ORDINARY SHARES |
| MIRUM PHARMACEUTICALS INC | 6795121 | 536746608 | COM |
| ARCUTIS BIOTHERAPEUTICS INC | 9874511 | 286755799 | COM |
| BRIDGEBIO PHARMA INC | 3545557 | 271199655 | COM |
| MBX BIOSCIENCES INC | 6652013 | 209804490 | COM |
| PHATHOM PHARMACEUTICALS INC | 12466489 | 206819053 | COM |
| MAZE THERAPEUTICS INC | 4567274 | 189222162 | COM |
| TREVI THERAPEUTICS INC | 10259409 | 128447801 | COM |
| KRYSTAL BIOTECH INC | 488460 | 120424928 | COM |
| DISC MEDICINE INC | 1260000 | 100056600 | COM |
| ERASCA INC | 22729436 | 84553502 | COM |
| KALVISTA PHARMACEUTICALS INC | 5039867 | 81393852 | COM |
| PALVELLA THERAPEUTICS INC NE | 722400 | 75613608 | COM |
| AVIDITY BIOSCIENCES INC | 983125 | 70912806 | COM |
| REVOLUTION MEDICINES INC | 797455 | 63517291 | COM |
| DYNE THERAPEUTICS INC | 3153082 | 61674284 | COM |
| TARSUS PHARMACEUTICALS INC | 728644 | 59661371 | COM |
| SAVARA INC | 9862301 | 59469675 | COM |
| CYTOKINETICS INC | 934642 | 59387153 | COM NEW |
| ABIVAX SA | 378300 | 51015647 | SPONSORED ADS |
| LEXEO THERAPEUTICS INC | 4424725 | 43937519 | COM |
| AGIOS PHARMACEUTICALS INC | 1279754 | 34834904 | COM |
| ACADIA PHARMACEUTICALS INC | 1297198 | 34648159 | COM |
| ZAI LAB LTD | 1902320 | 33556925 | ADR |
| RAPT THERAPEUTICS INC | 983333 | 33305489 | COM NEW |
| VOR BIOPHARMA INC | 2543939 | 33274722 | COM NEW |
| ASCENDIS PHARMA A/S | 133333 | 28431929 | SPONSORED ADR |
| AURA BIOSCIENCES INC | 5100000 | 27795000 | COM |
| MANNKIND CORP | 4225000 | 23955750 | COM NEW |
| VALNEVA SE | 2291666 | 20212494 | SPONSORED ADS |
| ALKERMES PLC | 700647 | 19604103 | SHS |
| EVOLUS INC | 2630665 | 17493922 | COM |
| IMMUNOCORE HLDGS PLC | 384782 | 13355783 | ADS |
| NEWAMSTERDAM PHARMA COMPANY | 500333 | 11507659 | *W EXP 99/99/999 |
| TRAVERE THERAPEUTICS INC | 241592 | 9231230 | COM |
| AUTOLUS THERAPEUTICS PLC | 4623324 | 9200415 | SPON ADS |
| ALLOGENE THERAPEUTICS INC | 3868750 | 5300188 | COM |
| DESIGN THERAPEUTICS INC | 521000 | 4886980 | COM |
| XILIO THERAPEUTICS INC | 5915091 | 3786841 | COM |
| IBIO INC | 1953467 | 3770191 | COM NEW |